Influencing the future of regenerative medicine

Spiderwort, one of OBI’s portfolio companies, is actively influencing the future of regenerative medicine. After successfully closing its $13.2M Series A funding round, the team will be moving forward to clinical trials in order to improve the quality of life for people around the world. Learn more.